Conditions

Medications suggested for second- and third-line treatments for diabetes management following treatment failure with metformin and sulfonylureas.

Patients with type 1 diabetes and prolonged increased HbA1c were found to be at two-times greater risk for dementia than those with well-managed HbA1c values.

Thorough knowledge of anti-diabetes medications found to lead to better management, adherence.

When combined with diet and exercise, GLP-1 medication showed significant weight loss compared to liraglutide and placebo, a new study finds.

In part 2 of this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the educational benefit from using CGM for type 2 diabetes.

Investigators find patients treated with GLP-1 drug had significantly lower number of amputations compared to placebo group.

Recent study shows improvements in insulin resistance and endotoxin-induced inflammation after taking probiotic supplementation, compared to placebo.

Recent studies show continued benefit in decreasing all-cause mortality from cardiovascular disease.

In part 2 of this Exclusive Interview, Rhoda Cobin talks with Diabetes in Control Medical Editor Joy Pape about the impact of obesity on PCOS.

People with type 2 diabetes found at increased risk for microvascular and macrovascular complications.